HyperClear:前立腺肥大症のレーザー治療
前立腺肥大症(BPH)を精密に治療するために設計された先進のレーザーシステムで、効果的な組織除去、尿流の改善、ダウンタイムの最小化を実現し、患者さんの治療成績を向上させます。
HyperClear represents an innovative laser therapy system designed to effectively remove surplus prostatic tissue in benign prostatic hyperplasia (BPH). Leveraging the LIFE (Laser-Induced Fiber Enucleation) method, HyperClear applies precise laser energy via a flexible fiber placed transurethrally to the obstructive zone, ablating the excess prostate tissue responsible for lower urinary tract symptoms (LUTS). This approach may be performed outpatient—often with local anesthesia—enhancing patient comfort while maintaining efficacy and safety.
High-Precision Laser Fiber
- Optimized Energy Delivery: The laser fiber is advanced through the urethra to the blocked area, targeting surplus prostate tissue while minimizing collateral damage.
- LIFE Method: Focused on selective tissue vaporization or enucleation, ensuring clean resection planes and predictable tissue removal.
Outpatient Feasibility
- Local Anesthesia: Allows many patients to undergo the procedure without the risks or recovery times associated with general anesthesia.
- Rapid Recovery: Less invasive than conventional transurethral resections, potentially reducing hospital stays and improving patient throughput.
Real-Time Visualization
- Precise Tissue Identification: Endoscopic imaging guides the laser fiber to the obstructive tissue, ensuring thorough clearance of the prostatic urethra.
- Controlled Ablation: The surgeon can finely tune laser energy to match the tissue’s vascularity and density, limiting the risk of deep thermal damage.
Efficient & Gentle Tissue Removal
- Targeted Laser Ablation: Precisely removes hyperplastic prostate segments that hinder urine flow, preserving healthy tissue zones.
- Hemostatic Effect: Laser energy also cauterizes small vessels during tissue vaporization, reducing intraoperative bleeding.
臨床上の利点と応用
Benign Prostatic Hyperplasia (BPH)
- Symptomatic Relief: Alleviates classic LUTS such as frequent urination, weak urine stream, and prolonged emptying times.
- Patient Selection: Suited for patients with moderate-to-severe BPH who seek a less invasive alternative to standard TURP or open prostatectomy.
Minimal Invasiveness
- Outpatient Possibility: Potentially performed under local anesthesia, minimizing hospitalization and facilitating early mobilization.
- Lower Bleeding Risk: Laser-based enucleation or vaporization significantly reduces hemorrhage compared to mechanical resection methods.
患者体験の向上
- Shorter Convalescence: Many patients resume daily activities sooner, with less postoperative discomfort or catheterization durations.
- Reduced Need for General Anesthesia: Local or spinal anesthesia lessens systemic risks, beneficial for older or comorbid patients.
Technical Specifications
仕様 | 詳細 / 価値 |
製品名 | CytroFIX®スーペリア・クラビキュラ・プレート |
素材 | High-Purity Titanium Alloy (e.g., Ti-6Al-4V ELI) |
Plate Profile | Low-profile, contoured for superior clavicle placement |
Locking Mechanism | Locking or non-locking titanium screws; optional variable-angle locking |
Screw Diameter | 2.7 mm or 3.5 mm (titanium cortical screws, depending on hole specification) |
Plate Thickness | ~2.0–2.5 mm (minimized profile) |
Hole Array | Multiple holes for bridging, compression, or combined fixation patterns |
ラジオパシティ | Titanium visible on fluoroscopy (optional etched markers) |
不妊症 | Provided non-sterile (autoclavable) or sterile, single use or reusable instrumentation (verify product line) |
賞味期限 | Indefinite if stored properly; reusable within recommended inspection cycles |
臨床適応症 | Midshaft/lateral clavicle fractures requiring superior plating, osteotomies, nonunion correction |
Regulatory Compliance | Conforms to ISO 13485, CE/FDA (region-specific), meets orthopedic implant standards |
Size & Ordering Matrix
Plate Length (mm) | Hole Count | Curvature | Compatible Screw | 商品コード | 備考 |
60 | 4 | Mild Superior Bend | 2.7 mm Locking/Non-Locking | CFX-SCL-60-4-27-Ti | Shorter plate for smaller fractures in lateral or mid-shaft |
70 | 5 | Mild Superior Bend | 2.7 mm Locking/Non-Locking | CFX-SCL-70-5-27-Ti | Extended coverage for mild to moderate fractures |
80 | 5 | Moderate Superior Bend | 2.7 or 3.5 mm Locking | CFX-SCL-80-5-MX-Ti | Bridges midshaft fractures with variable-angle options |
90 | 6 | Moderate Superior Bend | 3.5 mm Locking/Non-Locking | CFX-SCL-90-6-35-Ti | For larger or multi-fragment fractures requiring robust support |
100 | 7 | Enhanced Superior Contour | 3.5 mm Locking/Non-Locking | CFX-SCL-100-7-35-Ti | Accommodates more complex or extended fracture lines |
110 | 8 | Enhanced Superior Contour | 3.5 mm Locking/Non-Locking | CFX-SCL-110-8-35-Ti | Longest plate design for challenging multi-segment fractures |
関連商品
-
Renova腎瘻システム
続きを読む経皮的腎瘻造設術のためにデザインされた専用システムで、腎盂への確実なドレナージとアクセスを提供し、精度、患者の快適性、手技効率を向上させる。
-
NeoAblate 腫瘍アブレーションプローブ(軟部組織・肝臓用
続きを読む低侵襲な腫瘍切除のために設計された精密工学機器であり、制御されたエネルギーを供給することで、周囲の健康な組織へのダメージを最小限に抑えながら、軟部組織や肝腫瘍を効果的に治療する。
-
統合関節鏡ポンプ
続きを読むについて 統合関節鏡ポンプ は セーフ, 信頼できるそして ユーザーフレンドリー 流体管理ソリューション 継続的, パルスフリー 管理 関節内洗浄 そして 膨張圧 を通して すべて 関節鏡手術の段階。
-
脊髄腫瘍に対する骨内ラジオ波焼灼システム
続きを読む標的を絞った高周波エネルギーを供給するように設計された特殊な低侵襲装置で、周囲の健康な組織を温存しながら脊髄腫瘍を効果的に切除し、処置の回復時間を短縮する。